Weight loss drug Zepbound may help treat sleep apnea, …
WEBJun 21, 2024 · Tirzepatide, the medication in the weight loss drug Zepbound and also the diabetes treatment Mounjaro, appeared to reduce the severity of sleep apnea along with reducing weight and improving...
Zepbound: Weight Loss Drugs Can Help Reduce Sleep Apnea ... - Healthline
WEBJun 21, 2024 · Now, in a pair of clinical trials, researchers investigated whether tirzepatide could improve symptoms of obstructive sleep apnea (OSA), a condition in which individuals may stop breathing...
Obesity drug used in Mounjaro and Zepbound may help treat …
WEBJun 21, 2024 · A popular obesity drug may help treat a dangerous disorder in which people struggle to breathe while they sleep, a new study finds. Tirzepatide, the medication in the weight-loss drug Zepbound and also the diabetes treatment Mounjaro, appeared to reduce the severity of sleep apnea along with reducing weight and improving blood …
Weight loss drug Zepbound may help people with obstructive sleep apnea …
WEBApr 18, 2024 · Earlier studies have shown that when people lose weight, it can help improve their sleep apnea. The US Food and Drug Administration approved Zepbound to treat obesity in Novembe r.
A New Option to Treat Sleep Apnea: Weight-Loss Drugs - The New York Times
WEBJun 21, 2024 · New research showed that tirzepatide, the compound in Zepbound, improved symptoms of obstructive sleep apnea. Reporting from the American Diabetes Association conference in Orlando, Fla. Sue ...
Zepbound Weight Loss Drug May Help Relieve Sleep Apnea …
WEBApr 19, 2024 · In a new study, people with obesity who received weight-loss drug Zepbound saw a greater average reduction in sleep apnea events over the course of a year, compared to people who received...
Weight Loss Drug Zepbound May Reduce Sleep Apnea, Eli Lilly Says - Forbes
WEBApr 17, 2024 · A late-stage trial of Eli Lilly’s weight loss drug Zepbound showed promising results in treating sleep apnea symptoms in obese adults, the company announced Wednesday, the latest...
Transforming sleep apnea treatment with a metabolic drug
WEBJul 13, 2024 · Over 52 weeks, tirzepatide treatment led to a weight loss of approximately 16–17% and a reduction of 48–56% in the apnea–hypopnea index, compared with placebo. Tirzepatide also...
Eli Lilly's weight loss drug Zepbound found to reduce sleep apnea ...
WEBApr 17, 2024 · Left untreated, sleep apnea can lead to heart arrhythmias, heart failure and death. Lilly’s results were based on two studies of adults with obesity and moderate to severe obstructive sleep...
Sleep Apnea Reduced in People Who Took Weight-Loss Drug, Eli …
WEBApr 17, 2024 · The pharmaceutical manufacturer Eli Lilly announced on Wednesday that its obesity drug tirzepatide, or Zepbound, provided considerable relief to overweight or obese people who had obstructive ...